Base Genomics

Description: Base Genomics develops TAPS, a breakthrough epigenetic tech for sensitive, accurate, affordable DNA methylation analysis to detect early cancer via blood tests.

Country: UK

Based in: Oxford

Founded: 2019

Funding Stage: Seed

Tags: ['Biotechnology', 'Life Science', 'Transforming Patient']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.